Sandra Demaria Professor of Radiation Oncology

Publications

Sort by

Co-Author Network

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature communications. 2023 Academic Article GET IT
Times cited: 35
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6^th annual ImmunoRad conference. Oncoimmunology. 2023 Review GET IT
Times cited: 10
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. Nature communications. 2021 Academic Article GET IT
Times cited: 46
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 194

Sort by

Co-investigator Network

Precision use of radiation for in situ cancer immunization awarded by National Cancer Institute Principal Investigator 2025 - 2027
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation awarded by National Cancer Institute Principal Investigator 2022 - 2027
Converting HR+ Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Principal Investigator 2019 - 2026

Dynamics of Immune Response in Irradiated Rectal Cancer awarded by National Cancer Institute Co-Investigator 2022 - 2027
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer awarded by Breast Cancer Research Foundation, Inc. Co-Investigator 2024 - 2026
Converting HR Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Co-Investigator 2019 - 2026
Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by United States Department of Defense Co-Investigator 2021 - 2025
PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer awarded by National Cancer Institute Co-Investigator 2020 - 2025